Sir, Four quadrant sclerotomies for uveal effusion syndrome
We read with great interest Andrijević Derk et al 1 manuscript on medical therapy for uveal effusion syndrome (UES) and wish to add our suggestions whether surgical intervention is required. A number of surgical procedures have been described for the management of UES. 2 Herein, we describe our surgical management of a case of UES, demonstrating the global nature of the ocular pathology.
Case report
A 29-year-old man presented with a 2-week history of decreased vision in the right eye, on the background of poor ipsilateral vision for the past 2 years. He had no significant ocular or medical history. Over the following 4 months, there was no significant improvement in the subretinal fluid (SRF) (Figure 1b ) and the right visual acuity deteriorated to 'Hand Movements'. The patient subsequently underwent sclerotomies, as described above, in the superior nasal and superior temporal quadrants. At 1 month postoperatively, the right visual acuity improved to 20/120. The choroidal effusions decreased, demonstrated by a reduction in the SRF (Figure 1c ).
Comment
Our case highlights that even in cases of UES where there appears to be localised SRF, a sclerotomy in all four quadrants may be necessary. This reinforces the global nature of UES, as the localised SRF is likely to be inferior due to dependency. We suggest that sclerotomies may be required in four quadrants to decrease the overall resistance to choroidal fluid outflow thus facilitating drainage of fluid from the suprachoroidal and subretinal space. We read with great interest the recent correspondence by Wang et al 1 referring to our case series entitled 'Medical therapy for uveal effusion syndrome'. 2 Wang et al suggested in their case report that even in cases of UES with localised subretinal fluid, a surgical intervention with sclerotomies performed in all four quadrants may be necessary to successfully manage the patient.
BZ
With UES being so rare in occurrence, evidence for treatment comes from case reports or case series. Until our case series, recommended therapy for the treatment of UES has been surgery.
As reported in our paper, we managed to completely resolve the UES with medical therapy alone in two patients, whereas the third patient had to undergo surgery in the left eye. We decided to perform the surgery in a stepwise manner; with two inferior sclerotomies initially, leaving the option of further two sclerotomies for subsequent procedure, should the first one fail to resolve the effusion. After the surgical procedure, UES resolved completely, his VA increased from 20/50 to 20/20 and no recurrence was observed until the present day.
The differences between our case and the one reported by Wang et al should also take into account the different findings in the histology of the sclera. In our case, even though the sclera was thickened, the histology did not show any abnormalities in connective tissue and there was no excessive accumulation of mucin. According to a study by Uyama et al, 3 final results of the surgery depend on the subtypes of UES (nanophthalmic eye vs eye with normal axial length; abnormal sclera vs normal sclera on histology).
From the reported case of Wang et al, it is not obvious whether medical therapy was introduced before the Supplementary Information accompanies this paper on Eye website (http://www.nature.com/eye)
